What does DR. THOMAERE MARC-HUISARTSENGENEESKUNDE do?

DR. THOMAERE MARC-HUISARTSENGENEESKUNDE is a general practice in Landen. Private Limited, started on 31 December 2003, 1 establishment.

What is the address of DR. THOMAERE MARC-HUISARTSENGENEESKUNDE?

The registered office of DR. THOMAERE MARC-HUISARTSENGENEESKUNDE is located at Braakkouterstraat 17, 3400 Landen.

Is DR. THOMAERE MARC-HUISARTSENGENEESKUNDE still active?

Yes. According to the CBE (30 September 2026) DR. THOMAERE MARC-HUISARTSENGENEESKUNDE is active, legal situation “Normale toestand”, started on 31 December 2003.

Is DR. THOMAERE MARC-HUISARTSENGENEESKUNDE registered on Peppol?

Yes, DR. THOMAERE MARC-HUISARTSENGENEESKUNDE is registered on the Peppol network with ID 0208:0862454813.

What is the enterprise number of DR. THOMAERE MARC-HUISARTSENGENEESKUNDE?

The enterprise number of DR. THOMAERE MARC-HUISARTSENGENEESKUNDE is BE0862454813.

When was DR. THOMAERE MARC-HUISARTSENGENEESKUNDE founded?

DR. THOMAERE MARC-HUISARTSENGENEESKUNDE was founded on 31 December 2003.

Who are the directors of DR. THOMAERE MARC-HUISARTSENGENEESKUNDE?

According to the 2025 annual accounts, the directors of DR. THOMAERE MARC-HUISARTSENGENEESKUNDE are: Marc Thomaere.

Is DR. THOMAERE MARC-HUISARTSENGENEESKUNDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 December 2003; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. THOMAERE MARC-HUISARTSENGENEESKUNDE make in 2025?

DR. THOMAERE MARC-HUISARTSENGENEESKUNDE posted a profit after taxes of € 113,950 in financial year 2025.

What is the revenue of DR. THOMAERE MARC-HUISARTSENGENEESKUNDE?

As a small company, DR. THOMAERE MARC-HUISARTSENGENEESKUNDE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 177,739.

DR. THOMAERE MARC-HUISARTSENGENEESKUNDE (Private Limited)

Dossier DR. THOMAERE MARC-HUISARTSENGENEESKUNDE, printed on 30 September 2026 from databakkes.be/en/0862454813/dr-thomaere-marc-huisartsengeneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. THOMAERE MARC-HUISARTSENGENEESKUNDE from Landen, company number BE0862454813, closed financial year 2025 with a result of € 113,950 after tax. For that financial year DR. THOMAERE MARC-HUISARTSENGENEESKUNDE recorded a gross margin of € 177,739 and equity of € 555,104. Compared with financial year 2024, the result moved from € 102,624 to € 113,950. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Growing

€ 555,104

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 113,950

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 208,117

▼ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 57,290 paid out

50 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 86,526

▲ 81% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,111

▼ 64% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 35,670

▼ 10% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 130,515 Gross margin 2022: € 130,515 First fiscal year in the series	€ 148,521 Gross margin 2023: € 148,521 ▲ 14% vs 2022 (€ 130,515) Favourable step	€ 168,544 Gross margin 2024: € 168,544 ▲ 13% vs 2023 (€ 148,521) Favourable step	€ 177,739 Gross margin 2025: € 177,739 ▲ 5% vs 2024 (€ 168,544) Favourable step	▲ 5%
Profit after taxes	€ 72,572 Profit after taxes 2022: € 72,572 First fiscal year in the series	€ 91,026 Profit after taxes 2023: € 91,026 ▲ 25% vs 2022 (€ 72,572) Favourable step	€ 102,624 Profit after taxes 2024: € 102,624 ▲ 13% vs 2023 (€ 91,026) Favourable step	€ 113,950 Profit after taxes 2025: € 113,950 ▲ 11% vs 2024 (€ 102,624) Favourable step	▲ 11%
Equity	€ 397,949 Equity 2022: € 397,949 First fiscal year in the series	€ 429,723 Equity 2023: € 429,723 ▲ 8% vs 2022 (€ 397,949) Favourable step	€ 498,444 Equity 2024: € 498,444 ▲ 16% vs 2023 (€ 429,723) Favourable step	€ 555,104 Equity 2025: € 555,104 ▲ 11% vs 2024 (€ 498,444) Favourable step	▲ 11%
Total debts	€ 33,730 Total debts 2022: € 33,730 First fiscal year in the series	€ 56,797 Total debts 2023: € 56,797 ▲ 68% vs 2022 (€ 33,730) Unfavourable step	€ 51,983 Total debts 2024: € 51,983 ▼ 8% vs 2023 (€ 56,797) Favourable step	€ 73,908 Total debts 2025: € 73,908 ▲ 42% vs 2024 (€ 51,983) Unfavourable step	▲ 42%
Cash	€ 136,547 Cash 2022: € 136,547 First fiscal year in the series	€ 139,505 Cash 2023: € 139,505 ▲ 2% vs 2022 (€ 136,547) Favourable step	€ 217,938 Cash 2024: € 217,938 ▲ 56% vs 2023 (€ 139,505) Favourable step	€ 208,117 Cash 2025: € 208,117 ▼ 5% vs 2024 (€ 217,938) Unfavourable step	▼ 5%
Land & buildings	€ 70,392 Land & buildings 2022: € 70,392 First fiscal year in the series	€ 61,328 Land & buildings 2023: € 61,328 ▼ 13% vs 2022 (€ 70,392) Unchanged	€ 47,889 Land & buildings 2024: € 47,889 ▼ 22% vs 2023 (€ 61,328) Unchanged	€ 34,450 Land & buildings 2025: € 34,450 ▼ 28% vs 2024 (€ 47,889) Unchanged	▼ 28%
Retained profit	€ 385,549 Retained profit 2022: € 385,549 First fiscal year in the series	€ 417,323 Retained profit 2023: € 417,323 ▲ 8% vs 2022 (€ 385,549) Favourable step	€ 486,044 Retained profit 2024: € 486,044 ▲ 16% vs 2023 (€ 417,323) Favourable step	€ 542,704 Retained profit 2025: € 542,704 ▲ 12% vs 2024 (€ 486,044) Favourable step	▲ 12%
Dividend	€ 45,826 Dividend 2022: € 45,826 First fiscal year in the series	€ 59,252 Dividend 2023: € 59,252 ▲ 29% vs 2022 (€ 45,826) Unchanged	€ 33,902 Dividend 2024: € 33,902 ▼ 43% vs 2023 (€ 59,252) Unchanged	€ 57,290 Dividend 2025: € 57,290 ▲ 69% vs 2024 (€ 33,902) Unchanged	▲ 69%
Bank debt	€ 7,453 Bank debt 2022: € 7,453 First fiscal year in the series	€ 30,164 Bank debt 2023: € 30,164 ▲ € 22,711 vs 2022 (€ 7,453) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 30,164) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 431,680 Balance sheet total 2022: € 431,680 First fiscal year in the series	€ 486,520 Balance sheet total 2023: € 486,520 ▲ 13% vs 2022 (€ 431,680) Unchanged	€ 550,428 Balance sheet total 2024: € 550,428 ▲ 13% vs 2023 (€ 486,520) Unchanged	€ 629,011 Balance sheet total 2025: € 629,011 ▲ 14% vs 2024 (€ 550,428) Unchanged	▲ 14%

Key figures of DR. THOMAERE MARC-HUISARTSENGENEESKUNDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. THOMAERE MARC-HUISARTSENGENEESKUNDE?

What happened at DR. THOMAERE MARC-HUISARTSENGENEESKUNDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: profit of € 113,950 (▲ 11% vs 2024). filed late Source: NBB ↗
Dec 31, 2003 Start of the company according to the CBE. KBO
Dec 24, 2003 New establishment in Landen. KBO

In short

From € 72,572 profit in 2022 to € 113,950 profit in 2025.

Paid € 173,358 in corporate taxes since 2022.

Best year ever: 2025, with € 113,950 profit.

Paid out € 196,271 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. THOMAERE MARC-HUISARTSENGENEESKUNDE? We notify you, reason included.

Follow DR. THOMAERE MARC-HUISARTSENGENEESKUNDE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Marc Thomaere

DR. THOMAERE MARC-HUISARTSENGENEESKUNDE

Behind DR. THOMAERE MARC-HUISARTSENGENEESKUNDE is Marc Thomaere.

See the full network in the app

Directors

According to the 2025 annual accounts

Marc Thomaere

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Braakkouterstraat 17

3400 Landen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0862.454.813
VAT number: BE 0862.454.813
Registered office: Braakkouterstraat 17, 3400 Landen
Names & denominations: DR. THOMAERE MARC-HUISARTSENGENEESKUNDE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 31 December 2003
Peppol: Active · Active since 16 Nov 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗